PRESS RELEASE published on 06/11/2024 at 09:00, 1 year 8 months ago Informations privilégiées / Autres communiqués Medincell rejoint l’indice Euronext Tech Leaders, accédant à un vaste écosystème et renforçant sa visibilité auprès d'investisseurs internationaux. La technologie BEPO® innovante de Medincell est reconnue Croissance Innovation Medincell Euronext Tech Leaders BEPO®
BRIEF published on 05/10/2024 at 18:05, 1 year 9 months ago Medincell annonce les détails sur le capital et les droits de vote conformément à la réglementation Euronext Paris Droits De Vote Réglementation Financière Capital Social Medincell
BRIEF published on 05/10/2024 at 18:05, 1 year 9 months ago Medincell announces details on capital and voting rights in accordance with regulations Euronext Paris Share Capital Voting Rights Financial Regulation Medincell
PRESS RELEASE published on 05/10/2024 at 18:00, 1 year 9 months ago Informations privilégiées / Autres communiqués Annonce mensuelle des actions et droits de vote de Medincell sur Euronext Paris. Medincell développe des médicaments injectables à action prolongée pour divers domaines thérapeutiques Euronext Paris AMF Biopharmaceutique Medincell Médicaments Injectables
BRIEF published on 05/08/2024 at 12:35, 1 year 9 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 1 year 9 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 9 months ago Informations privilégiées / Autres communiqués Les résultats positifs de l'étude de phase 3 SOLARIS démontrent l'efficacité de TV-749, injection sous-cutanée mensuelle pour la schizophrénie par Teva et Medincell Santé Mentale Schizophrénie Medincell TV-749 Teva
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 9 months ago Inside Information / Other news releases Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
BRIEF published on 05/08/2024 at 09:05, 1 year 9 months ago Medincell Temporarily Suspends its Euronext Paris Listing Euronext Paris Press Release Financial Markets Medincell Share Suspension
BRIEF published on 05/08/2024 at 09:05, 1 year 9 months ago Medincell suspend temporairement sa cotation sur Euronext Paris Euronext Paris Marchés Financiers Communiqué De Presse Médine Partager La Suspension
Published on 02/14/2026 at 01:00, 1 day 5 hours ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 1 day 7 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 12 hours ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 15 hours ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 16:30, 13 hours 35 minutes ago Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 1 day ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 1 day 10 hours ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 1 day 11 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 1 day 11 hours ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:05, 1 day 12 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 12 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 12 hours ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 12 hours ago Nombre total d'actions et droits de vote - janvier 2026
